• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South America Point of Care Molecular Diagnostics Market

    ID: MRFR/MED/49961-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South America Point-of-care Molecular Diagnostics Market Research Report By Product Type (PCR Tests, Nucleic Acid Amplification Tests, Microarray, Next-Generation Sequencing, Other Genetic Tests), By Application (Infectious Diseases, Genetic Testing, Cancer Diagnosis, Metabolic Disorders), By End-use (Hospitals, Diagnostic Laboratories, Home Care Settings, Outpatient Clinics), By Technology (Isothermal Amplification, Polymerase Chain Reaction, Sanger Sequencing, CRISPR Technology), and By Regional (Brazil, Mexico, Argentina, Rest of South Am...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South America Point of Care Molecular Diagnostics Market 
Research Report- Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    South America Point of Care Molecular Diagnostics Market Summary

    The South America Point-of-care Molecular Diagnostics market is poised for substantial growth, with a projected valuation of 750 million USD by 2035.

    Key Market Trends & Highlights

    South America Point-of-care Molecular Diagnostics Key Trends and Highlights

    • The market is valued at 312.5 million USD in 2024, indicating a robust starting point for growth.
    • From 2025 to 2035, the market is expected to grow at a compound annual growth rate of 8.28 percent.
    • By 2035, the market is anticipated to reach 750 million USD, reflecting a significant increase in demand for molecular diagnostics.
    • Growing adoption of point-of-care testing due to the increasing need for rapid and accurate diagnostics is a major market driver.

    Market Size & Forecast

    2024 Market Size 312.5 (USD Million)
    2035 Market Size 750 (USD Million)
    CAGR (2025-2035) 8.28%

    Major Players

    Roche Holding AG, PerkinElmer Inc, Luminex Corporation, Trinity Biotech, BD (Becton, Dickinson and Company), Qiagen N.V., Abbott Laboratories, Thermo Fisher Scientific Inc, Cepheid, Siemens Healthineers, GenMark Diagnostics, LumiraDx, BioRad Laboratories, Hologic Inc

    South America Point of Care Molecular Diagnostics Market Trends

    The growing need for quick and accurate diagnostic solutions is propelling the South American point-of-care molecular diagnostics market's notable expansion. The increasing incidence of infectious diseases, such as bacterial, viral, and parasite infections, has increased the demand for prompt diagnostics in clinical settings, making it one of the major market drivers.

    Additionally, because molecular diagnostics may provide precise information about a person's health condition, their adoption is being fuelled by the increased emphasis on personalised medicine and the demand for customised treatment alternatives. This region offers a wealth of prospects, especially in underdeveloped communities where healthcare infrastructure is still in its infancy.

    Point-of-care diagnostics can now be delivered to rural populations through a unique channel because to the growth of telemedicine and improvements in mobile health technologies. Furthermore, more funding for molecular diagnostics may result from regional healthcare strategies targeted at enhancing disease management and control, which would improve access to cutting-edge medical treatments.

    Recent trends also show a move towards integrated diagnostics systems, which incorporate several testing modalities into one instrument to provide quicker results and more efficient workflow. Additionally, as more South American countries back programs to help domestic biotech enterprises, there is an increasing focus on local production and innovation.

    South America Point-of-care

    South America Point of Care Molecular Diagnostics Market Drivers

    Market Segment Insights

    South America

    South America Point-of-care Molecular Diagnostics Market Segment Insights

    Point-of-care

    Point-of-care Molecular Diagnostics Market Product Type Insights

    The South America Point-of-care Molecular Diagnostics Market presents a diverse landscape under the Product Type segment, encompassing various testing methodologies that are poised to enhance diagnostic capabilities in the region.

    Among these, PCR Tests stand out as a widely utilized method due to their ability to deliver rapid results with high sensitivity and specificity, making them crucial in infectious disease control, including outbreaks and public health emergencies.

    Nucleic Acid Amplification Tests have gained traction as they allow for the detection of pathogens and genetic disorders, significantly contributing to personalized medicine initiatives and timely treatment decisions, hence fostering patient-centric care.

    Next-Generation Sequencing offers transformative insights into genetics by enabling thorough genomic analysis, thus facilitating advancements in understanding rare diseases and cancer genomics. Lastly, Other Genetic Tests, which encompass a variety of methodologies focused on discovering genetic abnormalities and mutations, are critical for targeted therapies and improving health outcomes.

    The integration of these diverse methodologies responds to the increasing demand for accurate and rapid diagnostic solutions in South America, driven by the rising prevalence of infectious diseases and genetic disorders.

    Furthermore, the regional emphasis on improving healthcare infrastructure and investing in technology enhances the overall accessibility and utility of Point-of-care Molecular Diagnostics, ensuring that these advanced testing methods are integral to the future of healthcare in South America.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Point-of-care

    Point-of-care Molecular Diagnostics Market Application Insights

    The South America Point-of-care Molecular Diagnostics Market is segmented into various applications, which play a critical role in enhancing healthcare delivery. Among these applications, infectious diseases diagnostics hold considerable significance due to the high prevalence of diseases like COVID-19 and other epidemics in the region, necessitating rapid and accurate testing solutions.

    Genetic testing emerges as a vital tool, offering insights into hereditary conditions and aiding personalized medicine approaches that are gaining traction in South America. Furthermore, cancer diagnosis is increasingly important as cancer incidence rates rise, driving demand for early detection and monitoring methods in various countries across the continent.

    Metabolic disorders also represent a significant application area, particularly addressing the growing concerns surrounding diabetes and obesity, which pose public health challenges.

    Overall, the diverse applications within the South America Point-of-care Molecular Diagnostics Market collectively contribute to improving patient outcomes and reducing the burden on healthcare systems, reflecting an ongoing trend toward more accessible and efficient healthcare solutions.

    Point-of-care

    Point-of-care Molecular Diagnostics Market End-use Insights

    The End-use segment of the South America Point-of-care Molecular Diagnostics Market showcases a diverse landscape influenced by the need for efficient and timely diagnostics. Hospitals play a crucial role, leveraging Point-of-care diagnostics to enhance patient management and expedite decision-making processes, thereby driving better health outcomes.

    Diagnostic laboratories are increasingly adopting advanced molecular diagnostic techniques, ensuring accurate results which contribute to the rise in public health initiatives across the region. Home care settings are gaining traction, reflecting the growing trend towards patient autonomy and convenience, particularly in rural areas where access is limited.

    Outpatient clinics, being at the forefront of healthcare delivery, are integrating Point-of-care solutions to streamline patient flow and improve service efficiency. Together, these segments are reshaping the healthcare framework in South America, addressing increasing demands for rapid testing solutions and facilitating broader access to essential healthcare services.

    Point-of-care

    Point-of-care Molecular Diagnostics Market Technology Insights

    The Technology segment of the South America Point-of-care Molecular Diagnostics Market reflects a growing landscape driven by innovation and the need for rapid diagnostic solutions. Isothermal Amplification technology has gained momentum due to its simplicity and efficiency, enabling timely results without the need for complex equipment.

    Point-of-care

    Polymerase Chain Reaction continues to dominate as a cornerstone technique, known for its sensitivity and reliability in detecting genetic material. Sanger Sequencing offers comprehensive insights into genetic variations, making it valuable in personalized medicine and research applications.

    Meanwhile, CRISPR Technology is emerging as a groundbreaking tool in diagnostics, providing unprecedented precision in gene editing and disease detection.

    Each of these technologies contributes significantly to addressing public health challenges and disease monitoring in South America, fostering advancements in healthcare accessibility and quality. As the region's focus on improving health outcomes intensifies, these technologies are expected to play critical roles in shaping the future of diagnostics and pushing the boundaries of molecular biology.

    Point-of-care

    Get more detailed insights about South America Point of Care Molecular Diagnostics Market Research Report- Forecast to 2035

    Regional Insights

    The South America Point-of-care Molecular Diagnostics Market has shown significant growth, driven by the increasing demand for rapid and accurate diagnostic tools across the region. Brazil is a leader in this market, demonstrating a strong focus on improving healthcare infrastructure and access to Point-of-care molecular diagnostics, supported by ongoing investments in health technology.

    Mexico also plays a crucial role, showing a rising prevalence of chronic diseases that necessitate effective diagnostic solutions, while Argentina contributes with a growing emphasis on disease prevention and monitoring.

    In the Rest of South America, various countries are recognizing the importance of Point-of-care molecular diagnostics as a means to enhance health outcomes, leading to greater governmental and private sector initiatives to expand these services.

    The trends in the South America Point-of-care Molecular Diagnostics Market highlight a shift towards more personalized and timely medical care, aligning with global health trends and addressing the unique healthcare challenges faced by the region.

    As demand for these innovative solutions rises, opportunities for collaborations between local and international providers continue to emerge, paving the way for enhanced market dynamics in South America.

    South America Point of Care Molecular Diagnostics Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The South America Point-of-care Molecular Diagnostics Market has witnessed significant growth driven by advancements in technology, an increasing prevalence of infectious diseases, and a rising demand for rapid diagnostic solutions. The competitive landscape in this market is characterized by a mix of established global players and emerging local companies.

    The market is evolving with innovations in point-of-care testing, which aim to provide quicker results and improve patient outcomes in various healthcare settings. With the growing emphasis on personalized medicine and decentralized healthcare, companies are actively developing and marketing products tailored to meet the unique needs of the South American population.

    This dynamic environment creates both opportunities and challenges for participants, necessitating continuous adaptation and strategic positioning to maintain a competitive edge.

    Roche Holding AG emerges as one of the key players in the South America Point-of-care Molecular Diagnostics Market, leveraging its strong brand recognition and a comprehensive portfolio of diagnostic solutions. The company has established a robust market presence through strategic partnerships and a deep understanding of regional healthcare challenges.

    Roche's capabilities in innovative molecular diagnostics technologies, combined with extensive research and development efforts, enhance its competitive position. The company’s strengths lie in its ability to deliver reliable and timely diagnostic results, which are critical in improving patient management in both hospital and outpatient settings.

    Roche’s commitment to high-quality products and its active engagement in local healthcare initiatives further solidify its standing in the region.

    PerkinElmer Inc holds a significant foothold in the South America Point-of-care Molecular Diagnostics Market, focusing on delivering advanced technologies and solutions that address the specific needs of the local healthcare environment.

    The company's product offerings include a diverse range of diagnostic tools that enhance disease detection and management, particularly in infectious diseases and genetic testing. PerkinElmer's strengths include innovative product development, a strong distribution network, and a reputation for high-quality diagnostics, which have contributed to its market growth in this region.

    Additionally, the company has pursued strategic partnerships and collaborations to expand its reach and bolster its capabilities. Recent mergers and acquisitions have allowed PerkinElmer to enhance its product portfolio and strengthen its market presence, positioning itself as a leader in delivering point-of-care solutions tailored to the diverse healthcare requirements in South America.

    Key Companies in the South America Point of Care Molecular Diagnostics Market market include

    Industry Developments

    Recent developments in the South America Point-of-care Molecular Diagnostics Market include significant advancements in technology and product offerings by key players like Roche Holding AG, Abbott Laboratories, and BD (Becton, Dickinson and Company).

    The market has been witnessing increasing adoption of rapid testing solutions, particularly in response to public health needs driven by the COVID-19 pandemic, which surged demand for accessible diagnostic tools.

    There have been no notable mergers or acquisitions reported within this sector recently, highlighting a focus on organic growth and innovation among companies such as Thermo Fisher Scientific Inc and Siemens Healthineers.

    Additionally, the growth of the market is supported by increased healthcare investments and government initiatives aimed at enhancing diagnostic capabilities across Brazil, Argentina, and Colombia, as part of a broader strategy to improve public health infrastructure.

    Over the past two to three years, key events include the launch of innovative diagnostic platforms tailored to local healthcare needs, underscoring a dynamic shift towards precision medicine and rapid testing in this region, with an emphasis on affordability and accessibility for diverse populations.

    South America Point-of-care

    Market Segmentation

    Point-of-care Molecular Diagnostics Market End-useOutlook

    • Hospitals
    • Diagnostic Laboratories
    • Home Care Settings
    • Outpatient Clinics

    Point-of-care Molecular Diagnostics Market Regional Outlook

    • Brazil
    • Mexico
    • Argentina
    • Rest of South America

    Point-of-care Molecular Diagnostics Market Technology Outlook

    • Isothermal Amplification
    • Polymerase Chain Reaction
    • Sanger Sequencing
    • CRISPR Technology

    Point-of-care Molecular Diagnostics Market Application Outlook

    • Infectious Diseases
    • Genetic Testing
    • Cancer Diagnosis
    • Metabolic Disorders

    Point-of-care Molecular Diagnostics Market Product Type Outlook

    • PCR Tests
    • Nucleic Acid Amplification Tests
    • Microarray
    • Next-Generation Sequencing
    • Other Genetic Tests

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 288.5(USD Million)
    MARKET SIZE 2024 312.5(USD Million)
    MARKET SIZE 2035 750.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.284% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Roche Holding AG, PerkinElmer Inc, Luminex Corporation, Trinity Biotech, BD (Becton, Dickinson and Company), Qiagen N.V., Abbott Laboratories, Thermo Fisher Scientific Inc, Cepheid, Siemens Healthineers, GenMark Diagnostics, LumiraDx, BioRad Laboratories, Hologic Inc
    SEGMENTS COVERED Product Type, Application, End Use, Technology, Regional
    KEY MARKET OPPORTUNITIES Increasing prevalence of infectious diseases, Rising demand for rapid testing solutions, Technological advancements in diagnostics, Expansion of telemedicine services, Growing focus on personalized medicine
    KEY MARKET DYNAMICS growing prevalence of infectious diseases, increasing demand for rapid diagnostics, advancements in molecular technologies, rising healthcare expenditure, supportive government initiatives
    COUNTRIES COVERED Brazil, Mexico, Argentina, Rest of South America

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the South America Point of Care Molecular Diagnostics Market in 2024?

    The South America Point of Care Molecular Diagnostics Market is expected to be valued at 312.5 million USD in 2024.

    What is the projected market size in 2035 for the South America Point of Care Molecular Diagnostics Market?

    By 2035, the South America Point of Care Molecular Diagnostics Market is expected to reach 750.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the South America Point of Care Molecular Diagnostics Market from 2025 to 2035?

    The market is projected to grow at a CAGR of 8.284% from 2025 to 2035.

    Which region is anticipated to hold the largest market share in the South America Point of Care Molecular Diagnostics Market by 2035?

    Brazil is expected to dominate the market, reaching an estimated value of 290.0 million USD by 2035.

    What is the market size of the South America Point of Care Molecular Diagnostics Market in Argentina for 2024?

    In 2024, Argentina's market size for Point of Care Molecular Diagnostics is anticipated to be 40.0 million USD.

    Who are the key players in the South America Point of Care Molecular Diagnostics Market?

    Major players include Roche Holding AG, PerkinElmer Inc, and Abbott Laboratories among others.

    What is the projected market value for PCR Tests in the South America Point of Care Molecular Diagnostics Market by 2035?

    The PCR Tests segment is forecasted to be valued at 210.0 million USD by 2035.

    How much is the Nucleic Acid Amplification Tests segment expected to contribute to the market by 2035?

    By 2035, the Nucleic Acid Amplification Tests segment is expected to reach a value of 165.0 million USD.

    What growth opportunities exist within the South America Point of Care Molecular Diagnostics Market?

    Emerging trends include advancements in testing technology and increasing demand for rapid diagnostic solutions.

    What is the anticipated market size for Microarray tests by 2035 within the South America Point of Care Molecular Diagnostics Market?

    The Microarray segment is projected to grow to an estimated 80.0 million USD by 2035.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. South America Point of Care Molecular Diagnostics Market, BY Product Type (USD Million)
    45. PCR Tests
    46. Nucleic Acid Amplification Tests
    47. Microarray
    48. Next-Generation Sequencing
    49. Other Genetic Tests
    50. South America Point of Care Molecular Diagnostics Market, BY Application (USD Million)
    51. Infectious Diseases
    52. Genetic Testing
    53. Cancer Diagnosis
    54. Metabolic Disorders
    55. South America Point of Care Molecular Diagnostics Market, BY End Use (USD Million)
    56. Hospitals
    57. Diagnostic Laboratories
    58. Home Care Settings
    59. Outpatient Clinics
    60. South America Point of Care Molecular Diagnostics Market, BY Technology (USD Million)
    61. Isothermal Amplification
    62. Polymerase Chain Reaction
    63. Sanger Sequencing
    64. CRISPR Technology
    65. South America Point of Care Molecular Diagnostics Market, BY Regional (USD Million)
    66. Brazil
    67. Mexico
    68. Argentina
    69. Rest of South America
    70. Competitive Landscape
    71. Overview
    72. Competitive Analysis
    73. Market share Analysis
    74. Major Growth Strategy in the Point of Care Molecular Diagnostics Market
    75. Competitive Benchmarking
    76. Leading Players in Terms of Number of Developments in the Point of Care Molecular Diagnostics Market
    77. Key developments and growth strategies
    78. New Product Launch/Service Deployment
    79. Merger & Acquisitions
    80. Joint Ventures
    81. Major Players Financial Matrix
    82. Sales and Operating Income
    83. Major Players R&D Expenditure. 2023
    84. Company Profiles
    85. Roche Holding AG
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. PerkinElmer Inc
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Luminex Corporation
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Trinity Biotech
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. BD (Becton, Dickinson and Company)
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Qiagen N.V.
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Abbott Laboratories
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Thermo Fisher Scientific Inc
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Cepheid
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Siemens Healthineers
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. GenMark Diagnostics
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. LumiraDx
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. BioRad Laboratories
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. Hologic Inc
    164. Financial Overview
    165. Products Offered
    166. Key Developments
    167. SWOT Analysis
    168. Key Strategies
    169. References
    170. Related Reports
    171. South America Point of Care Molecular Diagnostics Market SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD Billions)
    172. South America Point of Care Molecular Diagnostics Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    173. South America Point of Care Molecular Diagnostics Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
    174. South America Point of Care Molecular Diagnostics Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    175. South America Point of Care Molecular Diagnostics Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
    176. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    177. ACQUISITION/PARTNERSHIP
    178. MARKET SYNOPSIS
    179. SOUTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    180. SOUTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    181. SOUTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USE
    182. SOUTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    183. SOUTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    184. KEY BUYING CRITERIA OF POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    185. RESEARCH PROCESS OF MRFR
    186. DRO ANALYSIS OF POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    187. DRIVERS IMPACT ANALYSIS: POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    188. RESTRAINTS IMPACT ANALYSIS: POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    189. SUPPLY / VALUE CHAIN: POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    190. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2025 (% SHARE)
    191. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
    192. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2025 (% SHARE)
    193. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    194. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USE, 2025 (% SHARE)
    195. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USE, 2019 TO 2035 (USD Billions)
    196. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    197. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    198. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY REGIONAL, 2025 (% SHARE)
    199. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
    200. BENCHMARKING OF MAJOR COMPETITORS

    South America Point of Care Molecular Diagnostics Market Segmentation

     

    • Point of Care Molecular Diagnostics Market By Product Type (USD Million, 2019-2035)

      • PCR Tests
      • Nucleic Acid Amplification Tests
      • Microarray
      • Next-Generation Sequencing
      • Other Genetic Tests

     

    • Point of Care Molecular Diagnostics Market By Application (USD Million, 2019-2035)

      • Infectious Diseases
      • Genetic Testing
      • Cancer Diagnosis
      • Metabolic Disorders

     

    • Point of Care Molecular Diagnostics Market By End Use (USD Million, 2019-2035)

      • Hospitals
      • Diagnostic Laboratories
      • Home Care Settings
      • Outpatient Clinics

     

    • Point of Care Molecular Diagnostics Market By Technology (USD Million, 2019-2035)

      • Isothermal Amplification
      • Polymerase Chain Reaction
      • Sanger Sequencing
      • CRISPR Technology

     

    • Point of Care Molecular Diagnostics Market By Regional (USD Million, 2019-2035)

      • Brazil
      • Mexico
      • Argentina
      • Rest of South America

     

    Point of Care Molecular Diagnostics Market Regional Outlook (USD Million, 2019-2035)

     

     

    • South America Outlook (USD Million, 2019-2035)

      • South America Point of Care Molecular Diagnostics Market by Product Type

        • PCR Tests
        • Nucleic Acid Amplification Tests
        • Microarray
        • Next-Generation Sequencing
        • Other Genetic Tests
      • South America Point of Care Molecular Diagnostics Market by Application Type

        • Infectious Diseases
        • Genetic Testing
        • Cancer Diagnosis
        • Metabolic Disorders
      • South America Point of Care Molecular Diagnostics Market by End Use Type

        • Hospitals
        • Diagnostic Laboratories
        • Home Care Settings
        • Outpatient Clinics
      • South America Point of Care Molecular Diagnostics Market by Technology Type

        • Isothermal Amplification
        • Polymerase Chain Reaction
        • Sanger Sequencing
        • CRISPR Technology
      • South America Point of Care Molecular Diagnostics Market by Regional Type

        • Brazil
        • Mexico
        • Argentina
        • Rest of South America
      • BRAZIL Outlook (USD Million, 2019-2035)
      • BRAZIL Point of Care Molecular Diagnostics Market by Product Type

        • PCR Tests
        • Nucleic Acid Amplification Tests
        • Microarray
        • Next-Generation Sequencing
        • Other Genetic Tests
      • BRAZIL Point of Care Molecular Diagnostics Market by Application Type

        • Infectious Diseases
        • Genetic Testing
        • Cancer Diagnosis
        • Metabolic Disorders
      • BRAZIL Point of Care Molecular Diagnostics Market by End Use Type

        • Hospitals
        • Diagnostic Laboratories
        • Home Care Settings
        • Outpatient Clinics
      • BRAZIL Point of Care Molecular Diagnostics Market by Technology Type

        • Isothermal Amplification
        • Polymerase Chain Reaction
        • Sanger Sequencing
        • CRISPR Technology
      • MEXICO Outlook (USD Million, 2019-2035)
      • MEXICO Point of Care Molecular Diagnostics Market by Product Type

        • PCR Tests
        • Nucleic Acid Amplification Tests
        • Microarray
        • Next-Generation Sequencing
        • Other Genetic Tests
      • MEXICO Point of Care Molecular Diagnostics Market by Application Type

        • Infectious Diseases
        • Genetic Testing
        • Cancer Diagnosis
        • Metabolic Disorders
      • MEXICO Point of Care Molecular Diagnostics Market by End Use Type

        • Hospitals
        • Diagnostic Laboratories
        • Home Care Settings
        • Outpatient Clinics
      • MEXICO Point of Care Molecular Diagnostics Market by Technology Type

        • Isothermal Amplification
        • Polymerase Chain Reaction
        • Sanger Sequencing
        • CRISPR Technology
      • ARGENTINA Outlook (USD Million, 2019-2035)
      • ARGENTINA Point of Care Molecular Diagnostics Market by Product Type

        • PCR Tests
        • Nucleic Acid Amplification Tests
        • Microarray
        • Next-Generation Sequencing
        • Other Genetic Tests
      • ARGENTINA Point of Care Molecular Diagnostics Market by Application Type

        • Infectious Diseases
        • Genetic Testing
        • Cancer Diagnosis
        • Metabolic Disorders
      • ARGENTINA Point of Care Molecular Diagnostics Market by End Use Type

        • Hospitals
        • Diagnostic Laboratories
        • Home Care Settings
        • Outpatient Clinics
      • ARGENTINA Point of Care Molecular Diagnostics Market by Technology Type

        • Isothermal Amplification
        • Polymerase Chain Reaction
        • Sanger Sequencing
        • CRISPR Technology
      • REST OF SOUTH AMERICA Outlook (USD Million, 2019-2035)
      • REST OF SOUTH AMERICA Point of Care Molecular Diagnostics Market by Product Type

        • PCR Tests
        • Nucleic Acid Amplification Tests
        • Microarray
        • Next-Generation Sequencing
        • Other Genetic Tests
      • REST OF SOUTH AMERICA Point of Care Molecular Diagnostics Market by Application Type

        • Infectious Diseases
        • Genetic Testing
        • Cancer Diagnosis
        • Metabolic Disorders
      • REST OF SOUTH AMERICA Point of Care Molecular Diagnostics Market by End Use Type

        • Hospitals
        • Diagnostic Laboratories
        • Home Care Settings
        • Outpatient Clinics
      • REST OF SOUTH AMERICA Point of Care Molecular Diagnostics Market by Technology Type

        • Isothermal Amplification
        • Polymerase Chain Reaction
        • Sanger Sequencing
        • CRISPR Technology

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials